Pancreatic Cancer Research

ResearcherNagasaki UniversityActive in the last 2 years

Hajime Matsushima

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1577-6587; OpenAlex author ID A5071370302. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 4

  1. Feasibility of serial cfDNA measurement after perflubutane microbubble (Sonazoid®) administration in patients with pancreatic ductal adenocarcinoma: a first-in… Co-author DOI 10.1186/s13104-026-07869-5↗
  2. Stress exacerbates pancreatic cancer both directly and indirectly by creating an immunosuppressive environment. Co-author DOI 10.1002/jhbp.1295↗
  3. Prognostic Impact of Relative Dose Intensity of Adjuvant Chemotherapy With S-1 on Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.21873/anticanres.15802↗
  4. Increased expression of PHD3 represses the HIF-1 signaling pathway and contributes to poor neovascularization in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00535-014-1030-3↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Susumu Eguchi · 4 shared papers, 2015–2026 · strength 0.60
  2. Hajime Imamura · 3 shared papers, 2022–2026 · strength 0.55
  3. Masaaki Hidaka · 2 shared papers, 2022–2023 · strength 0.30
  4. Takahiro Ikeda · 1 shared paper, 2023 · strength 0.18
  5. Takayuki Tanaka · 2 shared papers, 2015–2022 · strength 0.17
  6. Tamotsu Kuroki · 2 shared papers, 2015–2022 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.